Trial Outcomes & Findings for MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex (NCT NCT01450397)

NCT ID: NCT01450397

Last Updated: 2017-04-17

Results Overview

Change in Volume (millimeter cubed) of the Cord by MRI between Baseline and 30 days after XIAFLEX injection and manual manipulation.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

5 participants

Primary outcome timeframe

Baseline and 30 days

Results posted on

2017-04-17

Participant Flow

Subjects were enrolled from July 2011 to December 2011. Enrollment was completed in a medical clinic.

Participant milestones

Participant milestones
Measure
XIAFLEX
0.58 mg of Xiaflex injected into a palpable Dupuytren's cord
Overall Study
STARTED
5
Overall Study
COMPLETED
5
Overall Study
NOT COMPLETED
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
XIAFLEX
n=5 Participants
Patient who have received XIAFLEX
Age, Categorical
<=18 years
0 Participants
n=99 Participants
Age, Categorical
Between 18 and 65 years
1 Participants
n=99 Participants
Age, Categorical
>=65 years
4 Participants
n=99 Participants
Age, Continuous
67.6 years
STANDARD_DEVIATION 5.5 • n=99 Participants
Sex: Female, Male
Female
0 Participants
n=99 Participants
Sex: Female, Male
Male
5 Participants
n=99 Participants
Region of Enrollment
United States
5 participants
n=99 Participants

PRIMARY outcome

Timeframe: Baseline and 30 days

Change in Volume (millimeter cubed) of the Cord by MRI between Baseline and 30 days after XIAFLEX injection and manual manipulation.

Outcome measures

Outcome measures
Measure
XIAFLEX
n=5 Participants
Subjects receiving one Xiaflex injection
The Measured Change in Volume of the Cord by MRI Before and After XIAFLEX Injection and Manual Manipulation.
482 mm^3
Interval 188.0 to 670.0

Adverse Events

XIAFLEX

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Scott W. Wolfe

Hospital for Special Surgery

Phone: 212-606-1529

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place